MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE)

Is MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) A Buy Now?

According to our latest analysis, METpE could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on METpE, as trading bearish markets can be challenging and may result in losses.

1. RSI (Relative Strength Index): The RSI(14) value of 46.50 indicates that METpE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
2. STOCH (Stochastic Oscillator): The STOCH value of 21.54 indicates that METpE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.06 indicates that METpE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
4. ADX (Average Directional Index): The ADX value of 16.85 suggests that there may be some movement in price, but it lacks strength or conviction.
5. CCI (Commodity Channel Index): A CCI(14) value of -48.14 indicates that METpE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term METpE price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E financial reports and earnings history, MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) stock could reach $10.80 by 2030, $30.18 by 2040 and $66.90 by 2050. See the projected annual prices until 2050 of the MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E stock below:

• MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) is expected to reach an average price of $11.43 in 2035, with a high prediction of $11.91 and a low estimate of $5.58. This indicates an -43.57% change from the last recorded price of $20.26.
• MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) stock is projected to chart a bullish course in 2040, with an average price target of $29.50, representing an +45.66% change from its current level. The forecast ranges from a conservative $21.08 to a sky-high $30.18.
• Our analysts predict MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) to change +135.44% by 2045, soaring from $36.10 to an average price of $47.69, potentially reaching $48.54. While $36.10 is the low estimate, the potential upside is significant.
• MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) stock is expected to climb by 2050, reaching an average of $65.64, a +224.05% change from its current level. However, a wide range of estimates exists, with high and low targets of $66.90 and $51.12, respectively, highlighting the market's uncertainty.

MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Stock (METpE) Year by Year Forecast